drugset
drugset / Trial / NCT00254722

Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children

NCT00254722 ↗

Phase 1 Completed 10 enrolled The University of Texas Health Science Center, Houston
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if bone marrow progenitor cell (BMPC) autologous transplantation in children after isolated traumatic brain injury is safe and will improve functional outcome.

Timeline

Start
2006-04
Primary completion
2008-11
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject bone marrow progenitor cells Cell therapy 6e+06 cells/kg Intravenous

Indications

traumatic brain injury